Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39)

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

(2022) Ethan Basch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients

(2021) A. Al-Rashdan et al.   CLINICAL ONCOLOGY

Correlates of financial toxicity in adult cancer patients and their informal caregivers

(2021) Gelareh Sadigh et al.   SUPPORTIVE CARE IN CANCER

Mobile Application to Identify Cancer Treatment–Related Financial Assistance: Results of a Randomized Controlled Trial

(2021) Aaron M. Tarnasky et al.   JCO Oncology Practice

Time to add screening for financial hardship as a quality measure?

(2020) Cathy J. Bradley et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prevalence and Correlates of Medical Financial Hardship in the USA

(2019) K. Robin Yabroff et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Pilot Feasibility Study of an Oncology Financial Navigation Program

(2018) Veena Shankaran et al.   Journal of Oncology Practice

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

(2017) Ethan Basch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment

(2016) Ya-Chen Tina Shih et al.   CANCER

Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

(2016) Jonas A. de Souza et al.   CANCER

Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer

(2016) Christopher S. Lathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors

(2016) K. Robin Yabroff et al.   JOURNAL OF CLINICAL ONCOLOGY

Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer

(2016) Scott D. Ramsey et al.   JOURNAL OF CLINICAL ONCOLOGY

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

(2016) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients

(2015) Rosario Costas-Muniz et al.   ETHNICITY & HEALTH

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2015) Amylou C. Dueck et al.   JAMA Oncology

Population-Based Assessment of Cancer Survivors' Financial Burden and Quality of Life: A Prospective Cohort Study

(2015) S. Yousuf Zafar et al.   Journal of Oncology Practice

The development of a financial toxicity patient-reported outcome in cancer: The COST measure

(2014) Jonas A. de Souza et al.   CANCER

The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer

(2014) Dawn L. Hershman et al.   JNCI-Journal of the National Cancer Institute

Impact of Financial Burden of Cancer on Survivors' Quality of Life

(2014) Kathleen M. Fenn et al.   Journal of Oncology Practice

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

(2013) Carolyn Miller Reilly et al.   SUPPORTIVE CARE IN CANCER

Patient and oncologist discussions about cancer care costs

(2013) Nora B. Henrikson et al.   SUPPORTIVE CARE IN CANCER

Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care

(2012) Andrea J. Bullock et al.   Journal of Oncology Practice

Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions

(2011) Sonya Blesser Streeter et al.   Journal of Oncology Practice